Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 HKD | -0.83% | -1.65% | +13.33% |
Mar. 26 | Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024 | CI |
Mar. 25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
Sales 2022 | 1.28B 176M 1.38B | Sales 2023 | 1.15B 159M 1.24B | Capitalization | 1.43B 198M 1.54B |
---|---|---|---|---|---|
Net income 2022 | 358M 49.44M 386M | Net income 2023 | 326M 45.02M 352M | EV / Sales 2022 | 0.54 x |
Net cash position 2022 | 1.07B 148M 1.16B | Net cash position 2023 | 1.05B 145M 1.14B | EV / Sales 2023 | 0.33 x |
P/E ratio 2022 |
4.93
x | P/E ratio 2023 |
4.4
x | Employees | 1,143 |
Yield 2022 |
6.63% | Yield 2023 |
7.61% | Free-Float | 39.97% |
1 day | -0.83% | ||
1 week | -2.44% | ||
Current month | +1.69% | ||
1 month | +3.45% | ||
3 months | +1.69% | ||
6 months | +13.21% | ||
Current year | +14.29% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Xian Wu
CEO | Chief Executive Officer | 55 | 22-02-15 |
Yi jun Wu
DFI | Director of Finance/CFO | 59 | 02-11-30 |
Kei Ling Li
CHM | Chairman | 75 | 02-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kei Ling Li
CHM | Chairman | 75 | 02-09-30 |
Yung Lai Hung
BRD | Director/Board Member | 79 | 02-09-30 |
Hong Man Leung
BRD | Director/Board Member | 49 | 05-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 1.19 | -0.83% | 32 000 |
24-05-23 | 1.2 | -0.83% | 0 |
24-05-22 | 1.21 | +1.68% | 113,000 |
24-05-21 | 1.19 | -0.83% | 32,000 |
24-05-20 | 1.2 | -0.83% | 252,000 |
Delayed Quote Hong Kong S.E., May 23, 2024 at 04:08 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+14.29% | 233M | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- 2348 Stock